HSPD1 and cancer: Altogether, these discoveries are of importance on account of the novel therapeutic approaches aiming to restore cancer sensitivity to chemotherapeutics; for example, the combined treatment of cisplatin or docetaxel and the Hsp60 antibody led to a synergistic therapeutic effect on ovarian cancer cells of an epithelial origin [142].